News › Clinical Practice, Industry News, Patient Care

More new therapies under study for underarm sweat

November 13, 2018

The approval of the topical glycopyrronium tosylate (Qbrexza, Dermira) for primary axillary hyperhidrosis may soon be followed by other treatments for the condition, says David M. Pariser, M.D., FAAD, in a presentation made at the Fall Clinical Dermatology Conference taking place this week in Las Vegas.
“It’s really exciting that there is something new after a period of 12 years or so of drought in innovation,” said Dr. Pariser, of the Eastern Virginia Medical School in Norfolk, Va. “Not only is there something new, but there are several new things in the pipeline for patients.”
Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics
    • Moxie Announces Treatment Plans
    • Pacific Reliance Medical M&A Advisors Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Misinformation on Hyaluronic Acid (HA) Fillers Taking Over Your Practice? A New Fact-Based Campaign by Allergan Aesthetics Sets the Story Straight